汇宇制药: 持股5%以上股东减持股份计划公告

Core Viewpoint - The major shareholder Huang Qianyi of Sichuan Huiyu Pharmaceutical Co., Ltd. plans to reduce his shareholding by up to 12,708,000 shares, representing no more than 3% of the company's total shares, due to personal funding needs [1][2]. Shareholder Reduction Plan - The reduction period is set from April 28, 2025, to July 26, 2025, starting 15 trading days after the announcement [1]. - The reduction will be executed through centralized bidding or block trading, with a maximum of 4,236,000 shares through centralized bidding and 8,472,000 shares through block trading [1][2]. - Huang Qianyi currently holds 27,219,439 shares, accounting for 6.426% of the total shares [1][2]. Compliance and Commitments - Huang Qianyi has committed to comply with relevant laws and regulations regarding the reduction, ensuring that the plan aligns with previous commitments made [3][4]. - The company will disclose any changes in the reduction plan based on market conditions and stock price fluctuations [3][4].